Stay updated with breaking news from Gilead sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Burford Brothers Inc. bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 7,223 shares of the biopharmaceutical company’s stock, valued at approximately $585,000. Several other hedge funds have also […] ....
Burford Brothers Inc. bought a new position in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 7,223 shares of the biopharmaceutical company’s stock, valued at approximately $585,000. Several other hedge funds have also […] ....
Lindsey P. Sheehan, PharmD, MPA, MBA, discusses ongoing challenges of diagnosing and treating hepatitis C, emphasizing its increased incidence among younger populations and ongoing low rates of diagnosis. ....